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Public deliberation elicits informed perspectives on complex issues that are values-laden and lack
technical solutions. This Deliberative Methods Demonstration examined the effectiveness of public
deliberation for obtaining informed public input regarding the role of medical evidence in U.S.
healthcare.
We conducted a 5-arm randomized controlled trial, assigning participants to one of four deliberative
methods or to a reading materials only (RMO) control group. The four deliberative methods reﬂected
important differences in implementation, including length of the deliberative process and mode of
interaction. The project convened 76 groups between August and November 2012 in four U.S. locations:
Chicago, IL; Sacramento, CA; Silver Spring, MD; and Durham, NC, capturing a sociodemographically
diverse sample with speciﬁc attention to ensuring inclusion of Hispanic, AfricaneAmerican, and elderly
participants. Of 1774 people recruited, 75% participated: 961 took part in a deliberative method and 377
participants comprised the RMO control group. To assess effectiveness of the deliberative methods
overall and of individual methods, we evaluated whether mean pre-post changes on a knowledge and
attitude survey were statistically different from the RMO control using ANCOVA. In addition, we
calculated mean scores capturing participant views of the impact and value of deliberation.
Participating in deliberation increased participants' knowledge of evidence and comparative effec-
tiveness research and shifted participants' attitudes regarding the role of evidence in decision-making.
When comparing each deliberative method to the RMO control group, all four deliberative methods
resulted in statistically signiﬁcant change on at least one knowledge or attitude measure. These ﬁndings
were underscored by self-reports that the experience affected participants' opinions.
Public deliberation offers unique potential for those seeking informed input on complex, values-laden
topics affecting broad public constituencies.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Research, Health and Social
hington, DC 20007, USA.
r Ltd. This is an open access articleInterest in eliciting the public's views, values, and preferences to
inform health policy decisions has grown steadily in recent years,
as one approach to achieve better, more efﬁcient, and patient-
centered care (Abelson et al., 2012; Bolsewicz Alderman et al.,
2013; Mitton et al., 2009, 2011). Deeply held values, beliefs, andunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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debates, including what should be covered by health insurance,
who pays for care, who should participate in treatment decisions,
and who is ultimately responsible for health outcomes. Involving
the public in policy decisions can increase the transparency and
legitimacy of the decision-making process, make the healthcare
system more responsive to public values, and help inform health
policy decisions (Bastian et al., 2011; Carman et al., 2013b; Nguyen
et al., 2006; Siegel et al., 2013).
In the U.S., efforts to include the perspectives of lay individuals
have focused primarily on increasing patients' involvement in their
healthcare, rather than in broader health policy questions (Carman
et al., 2013a; Gold et al., 2007; Workman et al., 2013). Increasingly,
however, efforts to include patients and consumers have extended
beyond the clinical setting. For example, many hospitals are part-
nering with patients and family advisors in organizational de-
cisions (Johnson et al., 2008; Maurer et al., 2012) and the Patient-
Centered Outcomes Research Institute (PCORI) includes patients
in setting research priorities, evaluating research proposals, and
conducting research (Fleurence et al., 2013). Efforts to support
broadly improved healthcare quality depend upon the context of
decisions as well as public views regarding diverse aspects of
decisionmaking (Carman et al., 2010; Dobrow et al., 2004).
Historically, the public's views have been collected through
opinion surveys and focus groups that are designed to gather initial
and intuitive responses (Fishkin et al., 2004). Such methods are
generally designed to measure the prevalence and range of opin-
ions, not their stability or depth. In contrast, public deliberation is
an approach designed to capture in-depth and informed public
perspectives on complex topics. In public deliberation, members of
the public consider an ethical or values-based dilemma and are
asked to engage in the careful weighing of alternativedoften
competingdviews. Deliberation emphasizes participant education
and engagement in new information, usually provided through
written materials or conversations with experts; demands balance,
ensuring that all sides of an issue are considered; and encourages
participants to become social decision-makers along with consid-
ering and speaking from individual points of view (Fig. 1)
(Burkhalter et al., 2002; delli Carpini et al., 2004; Jacobs et al.,
2009).
Public deliberation has been used on a limited scale in the U.S. in
both privately and publicly sponsored projects. Applications of
deliberation to health topics have sought to provide guidance on
policy decisions such as what to include in health insurance ben-
eﬁts, issues surrounding patient consent, or healthcare priority
setting; and insights into the values driving public views on these
types of issues (Carman et al., 2013b; Danis et al., 2007; Gold et al.,
2007; Goold et al., 2005; Mitton et al., 2009). Although consider-
able theoretical and case-study literature endorses the value of
public deliberation, little empirical research has been conductedFig. 1. Public deliberation: prabout its effectiveness for health policy and few well-designed
studies have compared different deliberative methods (Abelson
et al., 2003b; Carman et al., 2013b).
The Deliberative Methods Demonstration, funded by the Agency
for Healthcare Research and Quality (AHRQ), sought to expand the
evidence base for public deliberation by evaluating its effectiveness
in obtaining informed public input and by comparing deliberative
methods. The focus of the demonstration was public views about
the degree to which medical evidence (or its absence) should be
used to determine healthcare choices, a concern central to the
agency's mission and research programs. We designed a random-
ized controlled trial (RCT) to assess the overall effectiveness of
deliberation compared to a control group and to compare different
deliberative approaches. We selected four distinct previously used
methods of deliberation and included core components of suc-
cessful deliberation identiﬁed through literature review (Carman
et al., 2013b). These methods varied on important aspects that
have implications for cost and feasibility for policymakers. This
paper reports on one of two aims of this research: to evaluate
whether public deliberation is an effective way to obtain informed
public input regarding complex health questions and identify the
most feasible deliberative methods. Findings summarizing the
input about appropriate and acceptable ways to use evidence are
reported separately (Carman et al., 2014).1. Methods
1.1. Measuring effectiveness
Based on an extensive literature review and input from a
Technical Expert Panel, we chose to measure the effectiveness of
deliberation using four outcomes (Carman et al., 2013b, 2014). The
ﬁrst is increase in participants' knowledge of the deliberative topic
e speciﬁcally, of medical evidence and comparative effectiveness
research. The intent of deliberation is to obtain informed public
opinion; improvement in knowledge is thus a necessaryd although
insufﬁcientd indicator of whether effective deliberation occurred.
The second measure, shift in participants' attitudes about the use of
evidence in decision-making, reﬂects the core assumption of public
deliberation that information, discussion, and understanding of
others' perspectives will alter participants' views as they reach a
more informed judgment on a topic. The third measure of effec-
tiveness is participants' self-report of the impact of deliberation, i.e.,
whether the participants believed that deliberation affected their
views and that participating in the processes had value. Studies of
deliberative processes frequently assess these outcomes as mea-
sures of deliberation effectiveness (Abelson et al., 2003a, 2007;
Deng and Wu, 2010; Timotijevic and Raats, 2007). The ﬁnal mea-
sure of effectiveness in our study is whether the deliberative pro-
cess can elicit from the public main themes and values regardingocess and core elements.
Table 1
Deliberative methods and RMO control group.
Method Number of
participants
per group
Structure and intensity Mode of communication Use of content experts
Brief Citizens' Deliberation
(BCD)
12 participants 2 h total; one session Face to face None
Community Deliberation (CD) 12 participants 6 h total; two 2.5-hour sessions 1
week apart with 1 h average online
time between sessions
Face to face; asynchronous
online between sessions
Online communication with
two experts via discussion board
Online Deliberative Polling®
(ODP)
12 participants 5 h total; four 1.25-hour sessions 1
week apart
Teleconference (synchronous
online)
Recorded Q&A via a moderator
with three experts
Citizens' Panel (CP) 24e30 participants 20 h total; one 3-day session: two
8-hour days and one 4-hour day
Face to face Presentations and Q&A with
seven experts
Reading materials only (RMO)
control group
N/A 1 h reading time at home Written materials received
via Web site
None
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content of the input obtained through deliberation, are reported
elsewhere (see Carman et al., 2014).
The speciﬁc research questions we address here are: 1) Do
participants in the deliberative methods e all four methods com-
bined e demonstrate greater changes in knowledge and attitudes
about the deliberative topics than the RMO control group? 2) Do
participants in each of the four deliberative methods demonstrate
greater changes in knowledge and attitudes about the deliberative
topics than the RMO control group? 3) What was the perceived
impact of deliberation on participants in each of the four deliber-
ative methods? Our analysis reported here addresses these ques-
tions providing evidence for the overall effectiveness of
deliberation, the effectiveness of the four methods included in this
study, and the impact of deliberation on the participants. Direct
comparisons between selected deliberative methods, the resources
required for each, and other aspects of the individual methods are
reported in Carman et al., 2014.1.2. Overall study design
We constructed a ﬁve-arm RCT assigning participants to one of
four deliberativemethods or a RMO control group.We designed the
four deliberative methods based on existing methods used in prior
public deliberations and incorporated differences in implementa-
tion that previous empirical research suggests most affect out-
comes, i.e., the number of participants, session length, mode of
interaction, and use of content experts (Abelson et al., 2003b;
Fishkin and Luskin, 2005; Fishkin et al., 2004; Gold et al., 2007;
National Institute for Health and Clinical Excellence, 2006; Paul
et al., 2008). The project was approved by the American Institutes
for Research Institutional Review Board (IRB00000436) and
received approval from the Ofﬁce of Management and Budget (OMB
No. 0935-0199).
The methods we tested were:
Brief Citizens' Deliberation (BCD): A single in-person, 2-hour
deliberative session with twelve participants. After partici-
pants reviewed educational materials, they discussed one case
study.
Online Deliberative Polling® (ODP): Four weekly online, 1.25-
hour deliberative sessions with twelve participants. During the
ﬁrst two sessions, participants reviewed educational materials
and explored key issues in one case study. Following discus-
sions, participants generated questions for experts who recor-
ded answers for participants to listen during the third session.
Participants discussed the answers and returned to previous
discussion points in the fourth session.Community Deliberation (CD): Two in-person, 2.5-hour
deliberative sessions, separated by one week of online interac-
tionwith twelve participants. During the ﬁrst week, participants
reviewed educational materials and explored issues in one case
study. Over the next week, they had the opportunity for online
discussion with group members and experts. In week two, they
returned to discussion of the ﬁrst case study and discussed a
second case study.
Citizens' Panel (CP): One in-person, 20-hour deliberative ses-
sion held over 2.5 days with twenty-four to thirty participants.
Participants reviewed educational materials and all ﬁve case
studies. Discussion occurred in small groups moderated by fa-
cilitators as well as in full-group sessions. Participants also could
interact live with experts (Table 1).1.2.1. Deliberation topic
Topics appropriate for deliberation should affect the common
good (Carman et al., 2013b; delli Carpini et al., 2004) and should be
genuinely of interest to the sponsor so that participants know that
their input is valued (Fishkin et al., 2004; Mallery et al., 2012). In
consultation with AHRQ, we developed the following deliberative
question:
Should individual patients and/or their doctors be able to make any
health decisions no matter what the evidence of medical effec-
tiveness shows, or should society ever specify some boundaries for
these decisions?
This question required participants to understand how medical
evidence is generated and used and to discuss the trade-offs for
individuals and society when evidence is or is not applied in
medical decisions. The question was designed to prompt partici-
pants to reveal which values were important to them in considering
the role of evidence for patients and physicians making healthcare
decisions.1.2.2. Structure of deliberative sessions
Prior to participation, all participants, including the RMO control
group, received reading materials describing the project's purpose.
These plain-language materials described medical research and
evidence and healthcare quality. Information on rising healthcare
costs and who pays for healthcare was included to provide context
for the discussions.
We developed ﬁve case studies to provide concrete illustrations
of the overall question and to help focus discussion. Topics for the
case studies were: the trade-offs in obtaining care at a regional,
high-volume hospital versus a local, low-volume hospital; the link
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vance of evidence in choosing treatment for coronary artery dis-
ease; comparing approaches to managing obesity; and comparing
approaches to treating or preventing a hypothetical
illness (Appendix). Each deliberative method used a different se-
lection of these case studies, depending upon the time available for
discussion. Participants in all methods discussed the case study on
hospital quality.
1.2.3. Eligibility and recruitment
We recruited participants whowere aged 18 or older; resided in
one of the four geographic locations selected for the study; were
comfortable reading and conversing in English; were never
employed as healthcare professionals or researchers; had not
participated in a study using interviews or focus groups in the past
six months; and were willing to participate in at least two of the
four types of deliberative methods based on descriptions of the
methods. Participants in all ﬁve arms were required to have
Internet access to avoid having Internet access confound compar-
isons between methods that required it and other methods. This
also made it possible to distribute readingmaterials and administer
surveys online.
The study was powered to ﬁnd small differences (with Cohen's
d ¼ 0.2; Cohen, 1988) between the pooled deliberation groups and
the RMO control group and medium differences (with Cohen's
d ¼ 0.5) between the individual methods and the RMO control
group. A medium effect size is consistent with that found in social
science studies generally (Lipsey andWilson,1993); we determined
that medium differences would be sufﬁcient for the latter com-
parisons, because minor differences likely would not be important
to sponsors deciding between methods given the meaningful dif-
ferences in costs to conduct the deliberations and burden to
participate.
We recruited 1774 persons from Chicago, IL; Sacramento, CA;
Durham, NC; and Silver Spring, MD. We selected these locations to
achieve diversity and used stratiﬁed sampling to ensure inclusion
of members of three AHRQ priority populations: Hispanic partici-
pants, AfricaneAmerican women, and the elderly. Participants
were contacted by a local commercial recruitment ﬁrm at each
location and screened by telephone or Internet. We then convened
76 groups between August and November 2012.
1.2.4. Randomization procedure
Multi-treatment randomized studies are designed to minimize
confounding bias by recruiting participants who are willing and
able to participate in any of the treatment options and then
randomizing among those options and the control arm. In this
study, however, using a standard randomization approach would
have excluded all but a small, atypical group of participants who
were willing and able to participate in all four deliberative
methods, because the burden for participation varied substantially
among methods.
To address this concern but maintain the advantages of
randomization, we developed a conditional randomization
approach. We required participants to be willing to participate in at
least two deliberation study arms but not necessarily all of them.
Recruits were ﬁrst randomly assigned to either deliberation or RMO
control; then, deliberation participants were randomly assigned to
one of the methods that they were willing and available to
participate in. This procedure resulted in deliberative groups and
control groups that were comparable on willingness and avail-
ability to participate. (Our analytic models addressed participants'
differences in willingness to participate between different delib-
erative methods when required for direct deliberative methods
comparisons (Carman et al., 2014; see Appendix H)).Finally, to enable us to monitor representation of priority pop-
ulations assigned to each deliberative method, we recruited and
randomized hard-to-reach participants early in the recruitment
process for each location. Because recruits indicated willingness
and availability to participate in more methods than we antici-
pated, we ﬁlled deliberative methods without difﬁculty and before
ﬁlling the control groups. We assigned a small number of partici-
pants recruited later in the processd many of them non-minor-
ityd to the control groups, compromising randomization to a
limited extent.
1.2.5. Data collection and measurement
We administered a pre- and post-deliberation survey of
knowledge and attitudes and a post-deliberation survey about
perceived deliberation quality and experience. We developed
knowledge and attitude questions speciﬁc to the topics discussed in
the deliberations and questions addressing deliberation quality and
experience using both new and existing items from other in-
struments (Kim et al., 2009; Rowe and Frewer, 2005; Timotijevic
and Raats, 2007). The survey development process involved
extensive expert review and two rounds of cognitive testing to
evaluate respondents' understanding of the questions and to
improve item validity.
The knowledge items focused on information in the educational
materials provided to participants and reﬂected knowledge we and
expert panel members considered necessary to meaningfully
deliberate the topics of interest, including concepts related to
healthcare in the U.S., the use of medical evidence, and comparative
effectiveness research. There were seven items coded dichoto-
mously (1 ¼ correct; 0 ¼ incorrect); scores were reported as the
percent correct, equivalent to the average score across the seven
items.
The attitude items address the use of medical evidence in
decision-making (Appendix). We used exploratory factor analysis
to deﬁne the underlying structure of survey items and to determine
where it was appropriate to calculate summary scores for the do-
mains of interest. All domains showed acceptable internal consis-
tency reliability as measured by Cronbach's alpha, based on the
commonly used threshold of alpha >0.7. Although we had no hy-
pothesis about the directionality of shifts in attitudes, we were
interested in whether participants moved toward or away from the
statements presented and so used relative rather than absolute
values for change in all analyses.
The deliberation quality and experience items capture a par-
ticipant's self-report of their experience and include two domains
assessing how participants were affected by and how much they
valued the experience (Appendix). In addition, we collected data on
personal and demographic characteristics.
1.2.6. Data analysis
The randomization process resulted in an approximately equal
distribution of participants by sociodemographic characteristics in
each deliberative method. However, it produced a different proﬁle
in the RMO control group on health insurance coverage, income,
and racial/ethnic groups. We addressed this issue by using sam-
pling weights for all comparisons of deliberative methods with the
RMO control group, a standard approach to compensate for un-
equal distributions. Participants were weighted to the U.S. Census
population distribution of the relevant variables in the geographic
location where they were selected.
Because the analyses were performed using the participant as
the unit of analysis, each deliberative session represented a cluster
of participants who shared the deliberation experience, which
could have caused outcome variables to be more similar within
these clusters. Independence is an underlying assumption of our
Table 2
Participant demographics and participation rate.
Demographic Number
recruited,
n ¼ 1774
Number of
shows, n ¼ 1338
(columnar %)
Number of no shows, n ¼ 436
(columnar %)
Show rate (%)
Method
Brief Citizen's Deliberation (BCD) 412 309 (23%) 103 (24%) 75
Online Deliberative Polling (ODP) 384 262 (20%) 122 (28%) 68
Community Deliberation (CD) 429 292 (22%) 137 (31%) 68
Citizen's Panel (CP) 133 98 (7%) 35 (8%) 74
RMO control 416 377 (28%) 39 (9%) 91
Location
Chicago, IL 420 326 (24%) 94 (22%) 78
Durham, NC 420 339 (25%) 81 (19%) 81
Silver Spring, MD 459 327 (24%) 132 (30%) 71
Sacramento, CA 475 346 (26%) 129 (30%) 73
Age
Under 65 1580 1175 (88%) 405 (93%) 74
Over 65 194 163 (12%) 31 (7%) 84
Gender
Male 797 599 (45%) 198 (45%) 75
Female 977 739 (55%) 238 (55%) 76
Race
NoneAfrican American 1274 944 (71%) 330 (76%) 74
African American 498 394 (29%) 104 (24%) 79
Ethnicity
Non-hispanic 1588 1208 (90%) 380 (87%) 76
Hispanic 186 130 (10%) 56 (13%) 70
Education
College or post grad 842 662 (49%) 180 (41%) 79
Some college, 2yr associate, or vocational 609 454 (34%) 155 (36%) 75
High school/GED or less 325 222 (17%) 103 (24%) 68
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(ICC) of outcomes within each deliberative group. We found a
negligible clustering effect (ICCs mostly below 0.02), and, as a
result, did not adjust the variances for ICC in these analyses.
Analysis assessing change in knowledge and attitudes was
limited to participants who completed both pre- and post-
deliberation surveys; the analysis assessing deliberation quality
and experience was limited to participants who completed all
surveys. To answer the question of whether deliberation is effec-
tive, we ﬁrst pooled participants from all deliberative methods to
compare deliberation to the RMO control condition. We evaluated
whether mean pre-post changes of the outcome variables were
equal across the different deliberative methods and the RMO con-
trol group, while statistically controlling for the effects of the
covariates using the analysis of covariance (ANCOVA) modeling
approach (SAS version 9.2), a type of multiple regression analysis.
We speciﬁed the following model:
KAi ¼ b0 þ b1pre­score þ b2DELIi þ dX þ εi
where the unit of analysis is the individual participant; and
KAi is the change in knowledge or attitude for participant i;
pre-score is the knowledge or attitude in the pre-survey for
participant i;
DELIi is a dummy variable indicating the intervention condition
towhich participant iwas assigned (e.g., DELIi¼ 1 if participant i
was assigned to a deliberative method (any method) and
DELIi¼ 0 if assigned to the control group);
X is a vector of the control variables including geographic
location to control for regional variation in knowledge and at-
titudes; and the participant's health status, experience with the
healthcare system, gender, age, marital status, education,
employment status, and bi-lingual status to control for personal
characteristics that might affect knowledge and attitudes;and ε represents the unexplained variance;
b2, is the key coefﬁcient used to determine if the change in
outcomes for all the deliberative methods combined is signiﬁ-
cantly different from the change in outcomes for the RMO
group.
To examine the effectiveness of each method as measured by
changes in knowledge and attitudes, we compared each delibera-
tive method alone to the RMO control group using a similar
ANCOVA modeling approach. Four ANCOVA models were ﬁtted to
the data, one for each deliberative method. The same set of nine
control variables was included in each model. We reported the
means for the deliberation quality and experience outcomes in
each deliberative method to capture participants' self-report of
their experience.
2. Results
2.1. Sample characteristics
Of the 1774 recruited, 961 participated in a deliberative method
and 377 were part of the RMO control group, an overall participa-
tion rate of 75 percent. The study sample reﬂected each location's
population in terms of sex, age, race, and ethnicity, based on U.S.
Census Bureau estimates (Table 2).
2.2. The overall effect of deliberation on knowledge and attitudes
Table 3 presents the difference in differences between the
pooled deliberation groups and the RMO control group on all
knowledge and attitude outcomes, reported as b values.
2.2.1. Knowledge
Knowledge scores increased for all groupsdthe RMO control
group and the combined deliberative groupsdreﬂecting improved
Table 3
Effect of deliberation on knowledge and attitudes: pooled deliberative groups versus reading materials only control.
Outcomes Method Sample N size Pre-mean Post-mean b SE
Knowledge (% correct) RMO control 347 39.8% 47.9%
All deliberation 882 38.3% 50.6% 0.14* 0.06
Attitudes toward using medical evidence in healthcare decisionmaking (possible values range from 1e5)
Importance of knowing about
medical evidence when making
healthcare treatment decisions
RMO control 347 4.4 4.4
All deliberation 883 4.4 4.5 0.55* 0.18
Medical research versus doctor's
knowledge about patient as
most important in medical
treatment decisionmaking
(individual item)
RMO control 347 2.7 2.6
All deliberation 880 2.6 2.8 0.64* 0.25
Providers and patients should
consider evidence over
preferences when making
treatment decisions
RMO control 347 2.9 2.9
All deliberation 882 2.9 2.9 0.33 0.19
Attitude toward mechanisms to support use of high volume hospitals (possible values range from 1e5)
Insurance companies should require
children who need heart surgery to
be treated at high-volume hospitals
(individual item)
RMO control 347 3.1 3.2
All deliberation 882 3.2 3.4 0.50 0.32
Hospitals should be required to achieve
a high success rate in order to continue
performing heart surgery on children
(individual item)
RMO control 347 3.9 3.9
All deliberation 882 3.9 3.9 0.10 0.26
Doctors who treat patients at
low-volume hospitals should
tell their patients if other
high-volume hospitals have
better results (individual item)
RMO control 347 4.1 4.2
All deliberation 882 4.0 4.1 0.11 0.20
Pre-mean indicates the mean score prior to deliberation; post-mean indicates mean score post deliberation; the b estimate is the difference between the pre-post change for
the deliberative groups and the pre-post change for the control group obtained from the analysis of covariance (ANCOVA).
*Indicates a statistically signiﬁcant difference between all methods and RMO control at p < 0.05.
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(Table 3). This change was measured from pre-treatment to post-
treatment, with the RMO control group increases in knowledge
demonstrating knowledge gains that improved the baseline
knowledge (prior to deliberation) for the deliberative groups.
Further, the improvement for the combined deliberative groups
had a statistically signiﬁcant effect when compared to the RMO
control group and controlling for the covariates.
2.2.2. Attitudes toward using medical evidence in healthcare
decision-making
Deliberation had a statistically signiﬁcant effect when compared
to the change that occurred in the RMO control, in shifting partic-
ipants' attitudes regarding:
 Importance of knowing about medical evidence when making
healthcare treatment decisions (factor) and
 Medical research versus doctor knowledge about the patient as the
most important consideration in making medical treatment de-
cisions (item).
There was no statistically signiﬁcant effect on the remaining
outcome related to the use of evidence.
2.3. The effect of individual methods on knowledge and attitudes
To determine the impact on participant knowledge and atti-
tudes of each deliberative method separately, we calculated an
estimate of the difference in differences between each deliberative
method and the RMO control group (Table 4).
2.3.1. Knowledge
Each group showed improvements in knowledge scorescapturing concepts presented in the background educational ma-
terials. The mean increases were, from lowest to highest increase:
RMO control 8.1%; Online Deliberative Polling® 10.7%; Community
Deliberation 11.6%; Brief Citizens' Deliberation 12.5%; and Citizens'
Panel 17.2%. Participants in Citizens' Panel and Brief Citizens'
Deliberation showed statistically signiﬁcant gains above what was
observed in the RMO control group.
2.3.2. Attitudes toward using medical evidence in healthcare
decision-making
Compared to the RMO control group, deliberation had a statis-
tically signiﬁcant impact on the shift in participants' attitudes
toward:
 Importance of knowing about medical evidence when making
healthcare treatment decisions (factor) for participants in three
methods: Citizens' Panel, Community Deliberation, and Online
Deliberative Polling®. This shift was statistically signiﬁcant even
though all participants deven RMO control e agreed with this
view at the outset;
 Medical research versus doctor's knowledge about patient as most
important in medical treatment decisionmaking (item) for two
methods: Community Deliberation and Brief Citizens' Deliber-
ation; and
 Providers and people should consider evidence over preferences
when making treatment decisions (factor) for Citizens' Panel.
2.4. Deliberation quality and experience
Only participants in the deliberative sessions completed the
survey on deliberation quality and experience, so there was no
measure of change or of comparison to the RMO control group. We
calculatedmeans for each groupwith a possible range of 1e4. Mean
Table 4
Effect of deliberative methods on knowledge and attitudes: each deliberative method versus RMO control.
Measure Method N Pre-mean Post-mean b SE
Knowledge (% correct) RMO control 347 39.8% 47.9%
BCD 272 39.6% 52.2% 0.04* 0.02
ODP 251 36.6% 47.4% 0.00 0.02
CD 263 39.3% 50.9% 0.03 0.02
CP 96 36.1% 53.3% 0.07* 0.02
Attitudes toward using medical evidence in healthcare decisionmaking (possible values range from 1e5)
Importance of knowing about medical evidence
when making healthcare treatment decisions
RMO control 347 4.4 4.4
BCD 273 4.4 4.4 0.04 0.06
ODP 251 4.4 4.5 0.14* 0.05
CD 263 4.4 4.5 0.11* 0.05
CP 96 4.4 4.6 0.27* 0.07
Medical research versus doctor's knowledge
about patient as most important in medical
treatment decisionmaking (individual item)
RMO control 347 2.7 2.6
BCD 271 2.6 2.8 0.19* 0.08
ODP 251 2.6 2.6 0.05 0.08
CD 262 2.6 2.8 0.22* 0.07
CP 96 2.6 2.8 0.17 0.11
Providers and patients should consider evidence
over preferences when making treatment decisions
RMO control 347 2.9 2.9
BCD 272 2.9 2.9 0.00 0.06
ODP 251 2.9 2.9 0.00 0.05
CD 263 2.8 3.0 0.10 0.06
CP 96 3.0 3.2 0.23* 0.09
Attitude toward mechanisms to support use of high volume hospitals (possible values range from 1e5)
Insurance companies should require children who need
heart surgery to be treated at high-volume hospitals
(individual item)
RMO control 347 3.1 3.2
BCD 272 3.2 3.4 0.11 0.10
ODP 251 3.3 3.5 0.14 0.10
CD 263 3.2 3.3 0.10 0.10
CP 96 3.3 3.5 0.15 0.14
Hospitals should be required to achieve a high success
rate in order to continue performing heart surgery
on children (individual item)
RMO control 347 3.9 3.9
BCD 272 3.8 3.7 0.14 0.09
ODP 251 4.0 4.0 0.09 0.08
CD 263 3.8 3.8 0.00 0.08
CP 96 3.8 3.9 0.14 0.12
Doctors who treat patients at low-volume hospitals
should tell their patients if other high-volume
hospitals have better results (individual item)
RMO control 347 4.1 4.2
BCD 272 4.1 4.2 0.08 0.07
ODP 251 4.0 4.1 0.03 0.06
CD 263 4.0 4.1 0.05 0.06
CP 96 4.0 4.2 0.00 0.09
Pre-mean indicates the mean score prior to deliberation; post-mean indicates mean score post deliberation; the b estimate is the difference between the pre-post change for
the deliberative groups and the pre-post change for the control group obtained from the analysis of covariance (ANCOVA).
*Indicates a statistically signiﬁcant difference between method and RMO control at p < 0.05.
K.L. Carman et al. / Social Science & Medicine 133 (2015) 11e20 17scores in both areas were high, 3 or above in all cases (Table 5).3. Discussion
3.1. Deliberation increased knowledge and shifted attitudes
Pooling the deliberative methods to compare to RMO controls
gave us the strongest measure of whether deliberative methods,
taken as a group and despite variation in their content, have aTable 5
Participants' self-reported evaluation of the impact and value of their deliberative
experience: mean scores for each method (possible values range from 1 to 4 with 4
being the highest value).
Measure Method Sample size Mean
Effect of deliberation on participants
(the discussion led me to change
some of my opinions, how much
did the educational materials affect
your opinions on the issues, etc.)
BCD 278 3.2
ODP 239 3.0
CD 261 3.3
CP 95 3.4
Perceived value of the event (I would
participate in activities like this in the
future, more events like this should
be held as a way of getting the views
of people throughout the country, etc.)
BCD 276 3.6
ODP 239 3.5
CD 260 3.7
CP 94 3.7
See Appendix A for full list of the components of these measures.greater impact on knowledge and attitudes than educational ma-
terials alone. The increase in knowledge among deliberative group
participants was about 50% greater than that for the RMO controls
(12.3% vs. 8.1%). Because the knowledge questions drew directly
from the educational materials provided to all participants, this
difference represents a clear effect of deliberation on information
gained and retaineddcontrary to ﬁndings in previous studies
(Muhlberger and Weber, 2006). Given the breadth of discussion
and opportunities to learn from experts in some of the methods,
our measurement of the impact of deliberation on knowledge is a
conservative one.
Deliberation also shifted participants' attitudes related to the
importance of medical evidence at a statistically signiﬁcant level.
Speciﬁcally, when considering the use of evidence in making
healthcare treatment decisions, deliberation had an impact on the
importance of knowing about medical evidence (factor) and the
importance of medical research versus doctor knowledge about the
patient (item). However, a shift did not occur in the measure pro-
viders and patients should consider evidence over preferences
when making treatment decisions (factor). These measures can be
seen as hierarchical in that one may be more willing to accept the
importance of knowing about medical evidencedor even to be
convinced that evidence is more important than a physician's
knowledge of a patientd before one would accept that evidence is
more important than preferences. Deliberation had an impact on
the “lower bar” of perceived importance but stopped short of the
strongest changes in attitude in this domain.
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All four deliberative methods showed effectiveness in changing
either knowledge or at least one attitude, as compared to the RMO
control group. (Of note, these results do not compare different
deliberative methods; see Carman et al., 2014 for selected methods
comparisons.)
On the knowledge measure, increases were statistically signiﬁ-
cant for Citizens' Panel and Brief Citizens' Deliberation. There were
changes in attitudes toward the use of medical evidence, an
outcome central to our deliberative question, for all methods. On
outcomes that assessed the importance of knowing about medical
evidence when making healthcare treatment decisions (factor)
there were shifts for three methods; on the importance of evidence
versus doctor's knowledge about the patient (item) there were shifts
for two methods; and on the importance of providers and people
considering medical evidence over preferences (factor) there was a
shift for one method. Again, the latter measure may be the most
difﬁcult to shift. The most intensive method, Citizens' Panel, was
the only method where participant shifts were observed in this
measure.
Participants across all methods believed that deliberation
impacted their opinions on the deliberative topic. In addition, they
placed high value on taking part in deliberation, as shown in high
ratings of the perceived value of the event, including willingness to
participate in similar activities in the future.
3.3. Other ﬁndings
There were no statistically signiﬁcant shifts on attitudes related
to the material in the hospital quality case study that all the groups
deliberated, likely due to the case study's complexity. We deliber-
ately created this case study to present moral and ethical trade-offs,
and discussions of the case often focused on evidence of clinical
effectiveness as the primary basis for deciding on a hospital, versus
importance of other aspects of healthcare, such as proximity to
home and family. Although many participants argued that clinical
outcome is the most important factor in quality healthcare, others
prioritized receiving personal, respectful care and felt this could be
best delivered in a low-volume hospital. When participants
assumed the role of town councilors in this case study, they
weighed having access to the “better” hospital against the potential
impact the local hospital losing business. In this case, strict
adherence to evidence of clinical effectiveness meant accepting
negative impacts on the communitydin contrast to the other case
studies, where implementing decisions based on evidence clearly
would improve community health outcomes as a whole (see
Appendix for full case studies).
3.4. Limitations
Using RCTs in social science research is inherently difﬁcult, with
challenges in implementing the intervention consistently, con-
trolling for external inﬂuences, and deﬁning and measuring out-
comes. Nevertheless, because RCTs mitigate a number of threats to
internal validity more effectively than other research designs, we
chose this approach and adapted it as necessary (Shadish et al.,
2002). Our requirement that participants agree to be randomly
assigned to one of at least two of the deliberative methods allowed
us to assure greater generalizability of our results. In fact, a sur-
prising third of participants indicated willingness to participate in
any of the methods. Our requirement that participants have access
to the Internet also had a potential effect on generalizability. To
mitigate the impact of this requisite, we accepted people with
limited Internet access and so included people with limitedcomputer and Internet skills in the study.
Another concern was differences in facilitation style among our
deliberative session facilitators, which had the potential to intro-
duce variation. To address this concern, we developed guides for
each method, specifying step-by-step activities for each part of the
session, important verbal probes, and staff roles and re-
sponsibilities. All guides were pilot tested and revised. Facilitators
completed debrieﬁng forms following each session describing and
providing rationale for deviations from protocol.
This study is the ﬁrst large-scale randomized comparison of
alternative methods of public deliberation. As such, it addresses the
ﬁrst stage in the logic model of the value of public deliberation for
policymaking: how public deliberation affects participants'
knowledge and attitudes. The second stagedthe impact of chang-
ing knowledge and attitudes on the information available to poli-
cymakersdand the third stagedthe impact of new kinds of
information on the decisions made by policymakersdand ulti-
mately the meaningfulness and value of public deliberation for
policymaking, remain for future research.
4. Implications
4.1. Use of deliberation to obtain public input
Many organizationsdresearchers, healthcare providers, and
public and private-sector purchasersdnow recognize that trans-
parency and multi-stakeholder collaboration are essential to
achieving better care, better health, and lower costs. Both civic and
patient engagement are becoming important components of a va-
riety of decision processes. This study demonstrates the impact of
public deliberation methods and highlights the potential of these
methods to obtain informed public views on complex topics
affecting broader constituencies. Diverse groups of individuals can
convene and successfully debate challenging healthcare issues,
share ideas for their resolution, and learn from experts and from
each other. The result is different input based on increased
knowledge and reconsidered attitudes.
Public deliberation may be particularly useful for healthcare
issues where members of the public have limited knowledge (or
even incorrect information) about a technically complex topic yet
hold strong beliefs and attitudes. Our data suggest that participants
had a deeper understanding of the issues under discussion. Further,
changes in attitude suggest that deliberation encouraged partici-
pants to learn more about the topic and listen and respond to other
points of view. Some have suggested that deliberation is a tool for
“seeing around corners,” providing valuable insight into what a
more informed public might say, and assisting policymakers in
anticipating and planning for changes in public attitudes. When
making decisions about research, priorities, or policy, these multi-
dimensional and informed views arguably provide an essential
ingredient in terms of public perceptions, values, and perspectives.
4.2. Areas for future research
4.2.1. Impact on participants
Although input from public deliberation can inform public
policy and programmatic decisions, many proponents also high-
light its impact on participants as an important outcome (Gastil
et al., 2008). Future studies could explore the ways in which par-
ticipants are affected (e.g., whether participants are more active in
their own healthcare, whether civic engagement is increased), and
how long that impact continues.
4.2.2. Impact of deliberation on the sponsor
Only a few case studies have reported how the input from
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practices (Carman et al., 2013b; Street et al., 2014). Assessing the
impact on the sponsor's decisions was beyond the scope of this
project, but it will be important to evaluate whether deliberative
sessions provide useful input to decision-makers.
4.2.3. Other measures of deliberation effectiveness
Further development of process measures, such as the repre-
sentativeness of deliberative groups or the ability of all participants
to contribute to discussions, are important areas for future work.
Similarly, the development of measures that assess the quality of
deliberative outputdor establish quality criteriadwould advance
evaluation efforts.
4.2.4. Multi-stakeholder deliberation
By design, we excluded healthcare professionals as participants
because of the potential that they could overly inﬂuence or inhibit
discussion. The experiment, however, demonstrated the ability of
the lay public to interact successfully with expert presenters.
Including participants with professional expertise may be beneﬁ-
cial, such as when patients or the public are involved in de-
liberations on medical research, hospital governance, or
community health assessment. An important question is how we
can support members of the public most effectively in these
situations.
5. Conclusion
Asmore public and private organizations work toward including
the public in healthcare program and policy decisions, questions
arise about how best to involve the public in shaping policies and
programs that affect everyone's health and healthcare. More
frequently used methods may include traditional survey and focus-
group approaches to public consultation, public or patient partici-
pation on advisory committees (Cambridge University Hospitals,
2014; National Institutes for Health, 2013), or public comment
mechanisms such as those used by AHRQ to gather input on draft
reports and research initiatives. Each of these methods offers
distinct advantages; most are used to gather stakeholder input
from those with an identiﬁed interest in a product or a policy
question. The methods are also consultive in nature because they
ask for responses to existing approaches, rather than partnership or
co-production of approaches to program and policy decisions
(Mallery et al., 2012).
Public deliberation offers unique potential for organizations
seeking informed public input that balances individual needs and
desires with broader societal needs and interests. It can also offer
the public the opportunity for stronger participation. In our study,
deliberation enabled diverse groups to learn about, explore, and
provide input on a complex healthcare issue. At the same time,
participants found great value in the process, and decision-makers
received new input reﬂecting the considered views of the public. In
a rapidly transforming healthcare system with changing consumer
roles and responsibilities, deliberation can be a critical tool in
developing and improving policies and programs tomeet the needs
of the public.
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